Related Experiment Video
Updated: Jun 26, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Allosteric Regulation and Inhibition of Coronavirus 3CLpro Revealed by HDX-MS
Abstract:
Coronavirus (CoV) infections have caused contagious and fatal respiratory diseases in humans worldwide. CoV 3-chymotrypsin-like proteases (3CLpro or Mpro) play an important role in viral maturation, and maintenance of their dimeric conformation is crucial for viral activity. Therefore, allosterically regulated dimerization of 3CLpro can be employed as a drug development target. Here, we investigated the allosteric regulatory mechanism of 3CLpro dimerization by using hydrogen/deuterium exchange coupled with mass spectrometry (HDX-MS) technology. We found that the FLAG tag directly coupled to the N-finger of 3CLpro significantly increased HDX kinetics at the dimer interface, and 3CLpro transformed from a dimer to a monomer. The 3CLpro mutants of SARS-CoV-2, which are monomeric, also exhibited increased deuterium exchange. Binding of the allosteric inhibitor Gastrodenol to most betacoronavirus 3CLpros led to increased allosteric deuterium exchange, resulting in the monomeric conformation of the CoV 3CLpro upon binding. Molecular dynamics (MD) simulation analysis further indicated the molecular mechanism of action of Gastrodenol on CoV 3CLpro: binding of Gastrodenol to SARS-CoV-2 3CLpro destroyed the hydrogen bond in the dimer interface. These results suggest that Gastrodenol may be a potential broad-spectrum anti-betacoronavirus drug.
Insights
Targeting coronavirus 3-chymotrypsin-like proteases (3CLpro) is key for drug development. The allosteric inhibitor Gastrodenol disrupts 3CLpro dimerization, suggesting its potential as a broad-spectrum antiviral drug.
Area of Science:
- Virology
- Biochemistry
- Drug Discovery
Background:
- Coronaviruses (CoVs) cause severe respiratory illnesses globally.
- 3-chymotrypsin-like proteases (3CLpro) are essential for CoV maturation and activity.
- Maintaining 3CLpro's dimeric form is critical for its function, making it a viable drug target.
Purpose of the Study:
- To investigate the allosteric regulation mechanism of 3CLpro dimerization.
- To explore the potential of Gastrodenol as a broad-spectrum anti-betacoronavirus agent.
Main Methods:
- Hydrogen/deuterium exchange mass spectrometry (HDX-MS) to study protein dynamics.
- Analysis of 3CLpro mutants and FLAG-tagged constructs.
- Molecular dynamics (MD) simulations to elucidate drug-target interactions.
Main Results:
- N-terminal FLAG tag and monomeric SARS-CoV-2 3CLpro mutants showed increased deuterium exchange at the dimer interface.
- Gastrodenol binding induced monomerization in most betacoronavirus 3CLpros.
- MD simulations revealed Gastrodenol disrupts dimer interface hydrogen bonds in SARS-CoV-2 3CLpro.
Conclusions:
- Allosteric regulation of 3CLpro dimerization is a druggable mechanism.
- Gastrodenol's ability to induce monomerization suggests it could be a potent antiviral.
- Gastrodenol shows promise as a broad-spectrum therapeutic for betacoronavirus infections.
Related Concept Videos
Allosteric Regulation
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Ligand Binding and Linkage

